Dan McKees fiscal year 2027 budget suggests
So it's going to change based on where you are at in life, where your symptoms are, where your exposures are, etc
GLP-1 Natural Alternatives: Supporting Metabolic Health Beyond Medications GLP-1 Natural Alternatives: Supporting Metabolic Health Beyond Medications | GLP-1 Natural Alternatives: Supporting Metabolic Health Beyond Medications GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have transformed the landscape of type 2 diabetes and obesity care
39 In the SCALE trial, which enrolled 3,731 overweight or obese adults, liraglutide 3.0 mg daily was shown to reduce both systolic and diastolic BP, with average delta of 2.8 mmHg (95% CI [3.56, 2.09) and 0.9 mmHg (95% CI [1.41, 0.37), respectively